ClinConnect ClinConnect Logo
Search / Trial NCT05250388

The Effect of Arthroscopic Bankart Repair on Anterior-posterior Glenohumeral Translation and Shoulder Proprioception in Patients With Traumatic Anterior Shoulder Instability: a Prospective Cohort Study

Launched by CATARINA MALMBERG · Feb 21, 2022

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Traumatic Anterior Shoulder Instability Shoulder Dislocation Glenohumeral Instability Glenohumeral Biomechanics Shoulder Biomechanics Glenohumeral Translation

ClinConnect Summary

This clinical trial is studying the effects of a specific shoulder surgery called arthroscopic Bankart repair on patients who have experienced traumatic shoulder dislocations. The goal is to see how this surgery can improve both the movement and sense of position (proprioception) of the shoulder joint over time. Researchers will use safe and non-invasive methods to measure these improvements. They hope to find that the surgery helps restore normal function and leads to better overall outcomes for patients.

To participate in this study, you need to be between 18 and 40 years old and have a history of traumatic shoulder dislocations that meet certain criteria. You should also be able to speak and understand Danish and be willing to follow the study's protocol, which includes attending follow-up appointments. Participants can expect to undergo assessments at 6 and 12 months after surgery to evaluate their shoulder's performance and any changes in their symptoms. This research aims to provide valuable insights into how effective this surgical repair is for individuals with shoulder instability.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-40 years
  • Unilateral traumatic anterior shoulder instability booked for arthroscopic Bankart repair according to the department's guidelines (extent of symptoms, suffer recurrent dislocations, positive apprehension and relocation test, limited bone loss)
  • Willing to adhere to the study protocol, herein attend follow-up
  • The patient must be able to speak and understand Danish
  • The patient must be able to give written informed consent
  • Exclusion Criteria:
  • Traumatic instability in the opposite shoulder
  • For one or both shoulders: posterior, multi-directional or atraumatic instability
  • For one or both shoulders: traumatic rotator cuff or biceps tendon tear, Superior Labrum from Anterior to Posterior tear (SLAP-lesion)
  • For one or both shoulders: traumatic fracture of proximal humerus (other than Hill-Sachs lesion), clavicula, scapula (other than glenoid) or dislocation of sternoclavicular or acromioclavicular joints
  • For one or both shoulders: atraumatic shoulder pathologies (e.g. frozen shoulder, symptomatic osteoarthritis of the shoulder or acromioclavicular joints, acute calcific tendinitis)
  • Pregnancy
  • Terminal illness or severe medical illness: American Society of Anesthesiology (ASA) score ≥3.

About Catarina Malmberg

Catarina Malmberg is a dedicated clinical trial sponsor focused on advancing medical research and innovation in healthcare. With a commitment to improving patient outcomes, the organization collaborates with leading researchers and healthcare professionals to design and implement clinical trials that adhere to the highest ethical and scientific standards. Catarina Malmberg emphasizes transparency, patient safety, and rigorous data analysis, ensuring that their studies contribute valuable insights to the medical community. Through its strategic partnerships and a patient-centered approach, the sponsor aims to bring impactful therapies and interventions to market, ultimately enhancing the quality of care for diverse populations.

Locations

Hvidovre, , Denmark

Patients applied

0 patients applied

Trial Officials

Catarina Malmberg, MD

Principal Investigator

Dept. of Orthopedic Surgery, Copenhagen University Hospital Hvidovre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials